ATE303136T1 - Wasserfreie ranitidinhydrochlorid enthaltende tablette mit zweischichtigem überzug und deren zusammensetzung - Google Patents
Wasserfreie ranitidinhydrochlorid enthaltende tablette mit zweischichtigem überzug und deren zusammensetzungInfo
- Publication number
- ATE303136T1 ATE303136T1 AT00925209T AT00925209T ATE303136T1 AT E303136 T1 ATE303136 T1 AT E303136T1 AT 00925209 T AT00925209 T AT 00925209T AT 00925209 T AT00925209 T AT 00925209T AT E303136 T1 ATE303136 T1 AT E303136T1
- Authority
- AT
- Austria
- Prior art keywords
- anhydrous
- ranitidine hydrochloride
- composition
- tablet containing
- coated tablet
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 229960001520 ranitidine hydrochloride Drugs 0.000 title abstract 3
- GGWBHVILAJZWKJ-KJEVSKRMSA-N ranitidine hydrochloride Chemical compound [H+].[Cl-].[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-KJEVSKRMSA-N 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999MI000740A IT1311915B1 (it) | 1999-04-12 | 1999-04-12 | Compressa anidra di cloridrato di ranitidina con rivestimento a doppiostrato e sua composizione. |
| PCT/EP2000/003330 WO2000061118A1 (en) | 1999-04-12 | 2000-04-11 | Anhydrous tablet of ranitidine hydrochloride with double-layer coating and its composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE303136T1 true ATE303136T1 (de) | 2005-09-15 |
Family
ID=11382663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00925209T ATE303136T1 (de) | 1999-04-12 | 2000-04-11 | Wasserfreie ranitidinhydrochlorid enthaltende tablette mit zweischichtigem überzug und deren zusammensetzung |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1171102B1 (de) |
| AT (1) | ATE303136T1 (de) |
| AU (1) | AU4400500A (de) |
| DE (1) | DE60022334D1 (de) |
| IT (1) | IT1311915B1 (de) |
| WO (1) | WO2000061118A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BG65305B1 (bg) * | 2001-06-05 | 2008-01-31 | "Унифарм" Ад | Лекарствена форма, съдържаща ранитидин |
| CN105030694A (zh) * | 2015-08-04 | 2015-11-11 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗胃溃疡的药物盐酸雷尼替丁组合物干混悬剂 |
| CN115944601A (zh) * | 2023-02-17 | 2023-04-11 | 山西太原药业有限公司 | 一种有效控制n-亚硝基二甲胺（ndma）生成的盐酸雷尼替丁胶囊制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK171127B1 (da) * | 1994-04-22 | 1996-06-24 | Gea Farmaceutisk Fabrik As | Ranitidintablet med et hydroxypropylmethylcelluloseholdigt overtræk samt fremgangsmåde til at tilvejebringe dette overtræk |
| EP0694540B1 (de) * | 1994-06-24 | 1998-08-19 | Ranbaxy Laboratories Limited | Verfahren zur Herstellung von Ranitidinhydrochlorid in der Kristallform 1 |
| US5853756A (en) * | 1995-01-11 | 1998-12-29 | J. B. Chemicals & Pharmaceuticals Limited | Controlled release formulations of Ranitidine |
| DE19511131A1 (de) * | 1995-03-27 | 1996-10-02 | Basf Ag | Mechanisch stabile feste Wirkstoffzubereitungsformen |
-
1999
- 1999-04-12 IT IT1999MI000740A patent/IT1311915B1/it active
-
2000
- 2000-04-11 EP EP00925209A patent/EP1171102B1/de not_active Expired - Lifetime
- 2000-04-11 AU AU44005/00A patent/AU4400500A/en not_active Abandoned
- 2000-04-11 AT AT00925209T patent/ATE303136T1/de not_active IP Right Cessation
- 2000-04-11 DE DE60022334T patent/DE60022334D1/de not_active Expired - Lifetime
- 2000-04-11 WO PCT/EP2000/003330 patent/WO2000061118A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU4400500A (en) | 2000-11-14 |
| DE60022334D1 (de) | 2005-10-06 |
| EP1171102B1 (de) | 2005-08-31 |
| ITMI990740A1 (it) | 2000-10-12 |
| IT1311915B1 (it) | 2002-03-20 |
| WO2000061118A1 (en) | 2000-10-19 |
| EP1171102A1 (de) | 2002-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200400471A1 (ru) | Оральная дозированная форма пропиверина | |
| CA2339991A1 (en) | Microemulsions as solid dosage forms for oral administration | |
| CA2316485A1 (en) | Sustained-release pharmaceutical composition | |
| RU94041836A (ru) | Производные амидина, смесь их изомеров или отдельные изомеры и их соли, фармацевтическая композиция с антагонистической в отношении лейкотриена в*004 активностью | |
| CA2251886A1 (en) | An oral pharmaceutical formulation containing ibandronate | |
| CA2382098A1 (en) | Sustained-release, oral pharmaceutical forms of administration | |
| CA2326517A1 (en) | New galenic preparations of meloxicam for oral administration | |
| ATE158504T1 (de) | Brausemischungen enthaltend ibuprofen und verfahren | |
| NO20030897D0 (no) | Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer | |
| KR960700061A (ko) | 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence) | |
| MXPA05007609A (es) | Antagonista de un receptor sensible al calcio. | |
| CA2361402A1 (en) | Bis-sulfonamides | |
| WO2002030467A3 (en) | Pharmaceutical composition containing honey for the treatment of wounds | |
| SE0102440D0 (sv) | New compound | |
| ID22763A (id) | Komposisi penstabil tibolon | |
| PL337279A1 (en) | Pharmaceutical with controlled releose containing inhibitor ace as an active substance | |
| ATE303136T1 (de) | Wasserfreie ranitidinhydrochlorid enthaltende tablette mit zweischichtigem überzug und deren zusammensetzung | |
| KR890006236A (ko) | 피페리디노 알칸올-충혈제거제 조합을 위한 약제학적 조성물 | |
| BE2016C017I2 (de) | ||
| GEP20043377B (en) | Pharmaceutical Complex | |
| NO20013601L (no) | Nye morfolinobenzamidsalter | |
| MXPA02006250A (es) | Derivados de butino diol. | |
| MY101266A (en) | Pharmaceutical formulations | |
| NZ505080A (en) | Pharmaceutical formulations containing a compound having an amidine group stabilized by an acid | |
| ATE258046T1 (de) | Pharmazeutische, metamizol enthaltende brauseformulierung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |